These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9830450)

  • 1. Variability of individual normal tissue radiation sensitivity. An international empirical evaluation of endogenous and exogenous response modifiers.
    Zimmermann JS; Kumpf L; Kimmig B
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():16-9. PubMed ID: 9830450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of predictive assays for acute and late radiation morbidity.
    Budach W; Classen J; Belka C; Bamberg M
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():20-4. PubMed ID: 9830451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronical recording and evaluation of acute radiation morbidity.
    Niehoff P; Galalae R; Zimmermann JS; Kimmig B
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():37-9. PubMed ID: 9830454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic documentation of acute radiation morbidity.
    Zimmermann JS; Seegenschmiedt MH; Niehoff P; Galalae R; Kimmig B
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():30-6. PubMed ID: 9830453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal tissue tolerance dose metrics for radiation therapy of major organs.
    Milano MT; Constine LS; Okunieff P
    Semin Radiat Oncol; 2007 Apr; 17(2):131-40. PubMed ID: 17395043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric radiation oncology in Germany: a study of availability and application.
    Bölling T; Ernst I; Könemann S; Willich N
    Klin Padiatr; 2008; 220(3):178-82. PubMed ID: 18478491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of acute radiation morbidity on therapeutic outcome.
    Zimmermann JS; Feldmann HJ; Dörr W
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():1-3. PubMed ID: 9830446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of radiotherapy in patients with collagen vascular disease.
    Lin A; Abu-Isa E; Griffith KA; Ben-Josef E
    Cancer; 2008 Aug; 113(3):648-53. PubMed ID: 18506734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of normal cells to ionizing radiation.
    Rodemann HP; Blaese MA
    Semin Radiat Oncol; 2007 Apr; 17(2):81-8. PubMed ID: 17395038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.
    Skala M; Rosewall T; Dawson L; Divanbeigi L; Lockwood G; Thomas C; Crook J; Chung P; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):690-8. PubMed ID: 17379434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
    Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors influencing the response of normal tissue to radiation].
    Masuda K; Jingu K; Hayabuchi N; Miyoshi M; Hirata H
    Gan No Rinsho; 1987 Oct; 33(13):1551-9. PubMed ID: 3694794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late effects consensus conference: RTOG/EORTC.
    Radiother Oncol; 1995 Apr; 35(1):5-7. PubMed ID: 7569013
    [No Abstract]   [Full Text] [Related]  

  • 16. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast-conserving therapy in the setting of collagen vascular disease.
    Chen AM; Obedian E; Haffty BG
    Cancer J; 2001; 7(6):480-91. PubMed ID: 11769860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
    Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
    Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.
    Timmerman RD
    Semin Radiat Oncol; 2008 Oct; 18(4):215-22. PubMed ID: 18725106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Scoring system for the evaluation of results of radiation therapy].
    Tsunemoto H; Morita S; Sakata S
    Gan No Rinsho; 1987 Oct; 33(13):1579-89. PubMed ID: 3121889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.